Servana AB (FRA:79T) Market Cap: €1.96 Mil (As of Jul. 08, 2026)


What is Servana AB Market Cap?

Servana AB FRA:79T Market Cap is €1.96 Mil as of Jul. 08, 2026. The stock has 3 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Servana AB ranks worse than 96.08% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Servana AB's share price for the quarter that ended in Mar. 2026 was €0.0002. Servana AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 7,254.92 Mil. Therefore, Servana AB's market cap for the quarter that ended in Mar. 2026 was €1.45 Mil.

Servana AB's quarterly market cap stayed the same from Sep. 2025 (€1.45 Mil) to Dec. 2025 (€1.45 Mil) and stayed the same from Dec. 2025 (€1.45 Mil) to Mar. 2026 (€1.45 Mil).

Servana AB's annual market cap declined from Dec. 2023 (€1.67 Mil) to Dec. 2024 (€0.37 Mil) but then increased from Dec. 2024 (€0.37 Mil) to Dec. 2025 (€1.45 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Servana AB's Enterprise Value for Today is €1.90 Mil.


Servana AB  (FRA:79T) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Servana AB Market Cap Related Terms


Servana AB Market Cap Historical Data

* Premium members only.

The historical data trend for Servana AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Servana AB Market Cap Chart

Servana AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.44 0.11 1.67 0.37 1.45

Servana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.37 1.45 1.45 1.45

FRA:79T vs ISRG, BDX, MDLN: Market Cap Comparison

For the Medical Instruments & Supplies subindustry, Servana AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Servana AB Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Servana AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Servana AB's Market Cap falls into.



Servana AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Servana AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=€0.0002*7254.916
=€1.45

Servana AB's Market Cap for the quarter that ended in Mar. 2026 is calculated as

Market Cap (Q: Mar. 2026 )=Share Price (Q: Mar. 2026 )*Shares Outstanding (EOP) (Q: Mar. 2026 )
=€0.0002*7254.916
=€1.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of €1.96 Mil mean?
Servana AB (FRA:79T) has a Market Cap of €1.96 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Servana AB and its competitors. According to the industry distribution chart, Servana AB ranks #833 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 96.1%.
Is Servana AB's Market Cap too high?
Servana AB's current Market Cap is €1.96 Mil. Based on the distribution chart, Servana AB ranks #833 out of 867 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Servana AB's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Servana AB ranks #833 out of 867 companies for Market Cap. This places Servana AB in the lower half of its industry. The industry median Market Cap is 121.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Servana AB and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Servana AB's current Market Cap is €1.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Servana AB stock overvalued right now?
Servana AB (FRA:79T) has a current Market Cap of €1.96 Mil. The current Market Cap is €1.96 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Servana AB (FRA:79T), the current Market Cap is €1.96 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Servana AB Business Description

Other Exchanges SERV:Sweden
Address Zinkgatan 2, Lomma, SWE, 234 35
Servana AB formerly, Medimi AB is engaged in the development, production, and marketing of medication products. It offers Medimi Pro and Medimi Smart computerized pill dispensers that are used by patients, consumers, and healthcare staff to follow their drug schedule. The company focus on the following market segments namely Pharmaceutical industry, Hospital and retirement homes, Home Health Care, Pharmacy and private care, and Connected Health (Telemedicine), E-Health and Integration in Other Systems.